Skip to main content
. 2018 Nov 8;5:163. doi: 10.3389/fcvm.2018.00163

Figure 5.

Figure 5

Schematic overview of phenotypic switch of contractile SMCs to osteoblast-like SMC by uptake of enzyme modified LDL in the medial layer and neo-intima in blood vessels. 1a: entry of circulating monocytes and transformation to macrophage foam cells provides enzymatic and inflammatory input for various modifications of native low density lipoprotein (LDL). 1b: Modification of LDL to oxidized LDL (oxLDL) by Phospholipase A2 (sPLA2), Lipoxygenase or Myeloperoxidase. oxLDL is readily taken by macrophages. 2a: Cholesterol esterase together with proteases (plasmin, metalloproteinases (MMPs) or cathepsin) generate non-oxidized enzymatic modified LDL (ELDL). ELDL is taken up by smooth muscle cells via macropinocytosis. 2b: uptake of ELDL activates cell signaling pathways (MAPK, ERK, NFkB) and downregulates mRNA for ectonucleotide pyrophosphatase/phosphodiesterase (ENPP-1), matrix gla protein (MGP) and upregulates mRNA for bone morphogenic protein 2 (BMP2), dentin matrix protein 1 (DMP1), osteopontin (SPP1), and osterix (SP7).